YZJ-4729 Shows Promise in Phase Ⅱ Trial for Postoperative Pain Relief
A Phase Ⅱ study is evaluating the efficacy and safety of YZJ-4729 in patients with moderate to severe acute pain after abdominal surgery.
Therapeutic Area
Therapeutic area intelligence for Analgesia with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.